Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia

• Main Authors: Wenxiu Lv (Author), Tianping Chen (Author), Shen Wang (Author), Chun Li (Author), Bo Zhang (Author), Liang Wang (Author), Fang Xv (Author), Fang Cao (Author), Jing Wang (Author), Li Chen (Author), Chenglin Liao (Author), Na Li (Author), Hongjun Liu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Relapsed/refractory (rel/ref) acute myeloid leukemia (AML) has a very high mortality rate. At present, hematopoietic stem cell transplantation (HSCT) is the most effective treatment for rel/ref AML. The remission of the primary disease before HSCT is crucial for the transplantation to be effective....